Seelos Therapeutics, Inc.
(NASDAQ : APRI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.64%178.391.3%$493.87m
CELGCelgene Corporation
-0.78%90.201.3%$431.91m
GILDGilead Sciences, Inc.
-3.23%65.040.9%$395.98m
ILMNIllumina, Inc.
-1.79%293.203.5%$387.83m
BIIBBiogen Inc.
-0.41%231.271.3%$347.69m
ARRYArray BioPharma Inc.
0.00%46.498.1%$287.88m
REGNRegeneron Pharmaceuticals, Inc.
-1.64%298.112.6%$250.63m
ALXNAlexion Pharmaceuticals, Inc.
-2.00%120.802.0%$206.12m
VRTXVertex Pharmaceuticals Incorporated
-2.22%174.131.9%$160.59m
SRPTSarepta Therapeutics, Inc.
-1.56%149.2614.7%$158.59m
AAgilent Technologies, Inc.
-2.05%68.691.6%$152.75m
EXASExact Sciences Corporation
-1.73%114.8824.1%$131.59m
SGENSeattle Genetics, Inc.
-2.05%75.076.5%$108.91m
INCYIncyte Corporation
-0.95%80.542.5%$90.89m
BLUEBluebird Bio, Inc.
-2.22%138.1214.3%$88.46m

Company Profile

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio include late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY.